Given the current market sentiment towards MSB now that the FDA are open to a BLA for Remestemcel-l in aGvHD in pediatric patients, what newsflow items are we predicting over the coming months and where do we think the share price will be?
Has anyone done an analysis based upon where we are at with both REVASCOR & REMESTEMCEL-L and the likely next newsflow items we should see coming through?
Upcoming Newsflow & Re-rate Estimations
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.015(1.57%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 96.0¢ | 97.0¢ | 91.5¢ | $1.137M | 1.221M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 968 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 35801 | 6 |
View Market Depth
| Last trade - 10.46am 29/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |